AI drug discovery platform for neurotherapeutics

We use AI and high-throughput mouse studies to discover therapeutics that modify neural activity in the brain. The initial focus is on epilepsies associated with autism and Parkinson’s disease with the potential to expand to any neurological disorder underlined by a dysfunction in neural activity. Our R&D is guided by AI models trained on high-density multimodal mouse data generated in-house. We are 3 Oxford-trained neuroscientists supported by an experienced SAB from Harvard, Science Corp (ex-Neuralink), EPFL, Meta, and UCL. In 1.5 months since landing in SF, we went from nothing to (1) opening and operating an animal lab in South SF, (2) obtaining a proof-of-concept in mice, (3) building a multimodal AI model that directs our screening approach and (4) submitting two provisional patents; all while utilizing less than 50% of our YC funding. 

neurotechnologybiotechtherapeutics

Total Open and Closed Positions

Total open positions, and positions newly closed since the previous update

Department Headcount Over Time

Open positions per department · top 6 at any point in the window

Newly Opened and Closed Positions

Position Churn Rate

Positions closed within 14 days of opening · a high rate suggests posting instability — duplicates, pulled listings, or roles filled through internal or off-market channels

Time-to-Fill Distribution

Days from open to close · closed positions only

Salary Trend Over Time

Monthly median base salary · USD · annualized · p25/p75 dashed

Salary Range by Department

Employment Type

Technical vs. Non-technical

Open positions · by department

Top Roles by Department

Seniority Mix

Derived from job title keywords

Equity Range by Department

Top Skills

Top Tech Stacks

Skills Trend

Change in share of postings · recent 3 months vs. prior 3 months

Tech Stack Evolution

Positions opened per month · top 5 technologies